找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202

[復(fù)制鏈接]
樓主: Clinton
41#
發(fā)表于 2025-3-28 16:49:03 | 只看該作者
42#
發(fā)表于 2025-3-28 19:36:14 | 只看該作者
https://doi.org/10.37307/b.978-3-503-20630-8. Sometimes pragmatic choices need to be made between candidate diagnostic frameworks. Various kinds of diagnostic difficulty are explored, including differences between research and clinical diagnostic categories, “not otherwise specified” categories, and stigmatized diagnoses.
43#
發(fā)表于 2025-3-29 02:47:03 | 只看該作者
44#
發(fā)表于 2025-3-29 06:29:20 | 只看該作者
45#
發(fā)表于 2025-3-29 08:39:16 | 只看該作者
Friedrich Rüffler,Robert A. Steinwenderationally agreed-upon classification system of disease (ICD). It is a complex process in which over 50 factors are known to exert an influence. They include individual characteristics of the clinician and their cognitive styles, ambient conditions, ergonomic features of the workplace, the patient an
46#
發(fā)表于 2025-3-29 13:11:05 | 只看該作者
47#
發(fā)表于 2025-3-29 19:20:51 | 只看該作者
Erkrankungen von Leber und Gallenwegen,universe of patients that could benefit from a novel therapy but the majority of patients with shared features of a disease. This framework fits the current model of clinical development and regulatory approval, but it must evolve when studying complex diseases which have multifactorial etiology and
48#
發(fā)表于 2025-3-29 22:09:38 | 只看該作者
49#
發(fā)表于 2025-3-30 02:49:54 | 只看該作者
https://doi.org/10.1007/978-3-531-90010-0 The Agency has a series of well-publicized review processes, thus ensuring that appropriate standards of safety and efficacy are met. The FDA also has emergency procedures available to expedite approval in special circumstances, such as a completely new treatment or a national emergency. The FDA do
50#
發(fā)表于 2025-3-30 07:30:04 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 03:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
山西省| 阆中市| 梨树县| 多伦县| 武安市| 鹿泉市| 台南市| 阿克陶县| 东山县| 乌拉特前旗| 化德县| 长岛县| 英吉沙县| 乌拉特中旗| 宣恩县| 合肥市| 新和县| 章丘市| 丘北县| 乌什县| 青海省| 故城县| 彭泽县| 德安县| 乐清市| 武城县| 灵山县| 察雅县| 宁蒗| 泗阳县| 开封市| 西平县| 和田市| 屯门区| 洛浦县| 松滋市| 苏尼特右旗| 潼关县| 山阳县| 元谋县| 仁化县|